| ST003481 Therapeutic potential of galactooligosachaccharides and Lactobacillus reuteri supplementation on dextran sulfate sodium-induced gut inflammation | ||||
| Limit by pathway class: | ||||
| Pathway name (# of metabolites detected in this study) | HMDB pathway | KEGG pathway |
|---|---|---|
| Alpha Linolenic Acid and Linoleic Acid Metabolism (1) | SMP0000018 | map00592 |
